Federal grants to Vascular Vision Pharmaceutical Co
Vascular Vision Pharmaceutical Co in Wynantskill, New York received $3.1 million in federal grants from fiscal 2021 to 2025, across 1 award. Its largest program was Cardiovascular Diseases Research, with $3.1 million. It had no new grant money in fiscal 2025.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$3.1 million
- Awards1
- Awarded in FY 2025$0
- Largest award$3.1 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 1 | $996,212 |
| FY 2023 | 1 | $1.0 million |
| FY 2024 | 1 | $1.0 million |
| FY 2025 | 0 | $0 |
Programs that fund Vascular Vision Pharmaceutical Co
| Program | Awards | Amount |
|---|---|---|
| Cardiovascular Diseases Research | 1 | $3.1 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 1 | $3.1 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Sulfated non-anticoagulant heparin nanoparticle (VVP728) for sickle cell disease management - summary: sickle cell disease (SCD) primarily afflicts african-americans in the us, exacerbating an existing health disparity. Approximately 1 in 13 african-american babies is born with the sickle cell trait | Cardiovascular Diseases Research | September 23, 2022 | $3.1 million |
Questions people ask
How much federal grant money does Vascular Vision Pharmaceutical Co get?
$3.1 million in 1 grant award from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Vascular Vision Pharmaceutical Co the most?
The Department of Health and Human Services, with $3.1 million in 1 award.
What is Vascular Vision Pharmaceutical Co's largest federal grant?
$3.1 million under Cardiovascular Diseases Research, with its first action in the period on September 23, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Largest federal grant recipients in New York · Federal grants in New York